Učitavanje...
IT-12 WT1 PEPTIDE VACCINATION AGAINST GLIOMAS; COMBINATION WITH TEMOZOLOMIDE, BIOMARKERS AND IMMUNOLOGICAL RESPONSE
We report the long-term outcome on phase I study of combined WT1 peptide vaccination/temozolomide against newly diagnosed glioblastomas. Immunological biomarker and response were investigated in trials targeting newly diagnosed and recurrent cases. The survival analysis was performed on 7 patients i...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218228/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.10 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|